Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.48
-0.45 (-1.41%)
Oct 30, 2026, 4:00 PM EST - Market closed
Maze Therapeutics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Maze Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $62.54. The average 1-year stock price forecast is 98.67% higher than the current stock price, while the lowest is $46 (+46.12%) and the highest is $110 (+249.43%).
Price Target: $62.54 (+98.67%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 13 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $110 | Buy | Maintains | $110 | +249.43% | Oct 26, 2026 |
| Citi | Citi | Buy Maintains $50 | Buy | Maintains | $50 | +58.83% | Oct 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $75 | Buy | Initiates | $75 | +138.25% | Oct 19, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +74.71% | Oct 15, 2026 |
Financial Forecast
Revenue This Year
20.00M
Revenue Next Year
7.48M
from 20.00M
Decreased by -62.58%
EPS This Year
-2.73
from -3.05
EPS Next Year
-3.19
from -2.73
EPS and Forward PE are based on non-GAAP adjusted numbers.